Anti-inflammatory effects of inotropic drugs in the treatment of septic shock: Another piece to the puzzle

Critical Care Medicine

Volumn 29, Issue 9, 2001, Pages 1837-1838

  Ronco, J J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti inflammatory therapy; Catecholamines; Cytokines; Enoximone; Sepsis; Septic shock; Tumor necrosis factor

Indexed keywords

ADENOSINE PHOSPHATE; ADRENERGIC RECEPTOR; CATECHOLAMINE; CYTOKINE; DOBUTAMINE; ENOXIMONE; HYPERTENSIVE AGENT; INOTROPIC AGENT; LIDOCAINE; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CELL DAMAGE; CYTOKINE RELEASE; DRUG EFFECT; DRUG METABOLISM; HEPATIC VEIN; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LIVER BLOOD FLOW; LIVER FUNCTION; NOTE; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0034841152     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200109000-00032     Document Type: Note

References (10)

1. The inflammatory balance in human sepsis
2. Efficacy and safety of recombinant human activated protein C for severe sepsis
3. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients
4. Serum cytokine levels in human septic shock: Relation to multiple-system organ failure and mortality
5. Importance of underlying mechanism and genotype on outcome of sepsis trials
6. Hepatic response to sepsis: Interaction between coagulation and inflammatory processes
7. Effect of norepinephrine on the outcome of septic shock
8. Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients
9. Genetic markers in sepsis
10. Early prognosis in severe sepsis via analyzing the monocyte immunophenotype